AVBP
ArriVent BioPharma, Inc.
$34.18
-0.31 (-0.90%)
At close · Jul 7
Market Cap
$1.56B
Shares
46,574,928
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.
Earnings call
FY26 · Q1
2026-05-11
ArriVent BioPharma, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.96
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
ArriVent BioPharma, Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-10
ArriVent BioPharma, Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-0.83
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
ArriVent BioPharma, Inc. Q2 FY2025 Earnings Call
Diluted EPS
$-0.90
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
ArriVent BioPharma, Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-1.90
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-03
ArriVent BioPharma, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-14
ArriVent BioPharma, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-0.61
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
ArriVent BioPharma, Inc. Q2 FY2024 Earnings Call
Diluted EPS
$-0.65
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
ArriVent BioPharma, Inc. Q1 FY2024 Earnings Call
Diluted EPS
$-0.70
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-28
ArriVent BioPharma, Inc. Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–10 of 10 earnings calls